Mayinglong Pharmaceutical Group Co (SHSE:600993) Cyclically Adjusted Book per Share: ¥0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600993 Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
94 GF Score
Price ¥23.18
GF Value ¥29.81
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Mayinglong Pharmaceutical Group Co Cyclically Adjusted Book per Share?

Mayinglong Pharmaceutical Group Co SHSE:600993 -0.17% 94 Cyclically Adjusted Book per Share is ¥0.00 as of Jun. 2026. GuruFocus rates SHSE:600993 with a GF Score™ of 94/100 and a GF Value™ of ¥29.81 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Mayinglong Pharmaceutical Group Co's adjusted book value per share for the three months ended in Jun. 2026 was ¥10.338. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Mayinglong Pharmaceutical Group Co's average Cyclically Adjusted Book Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Mayinglong Pharmaceutical Group Co was 12.10% per year. The lowest was 8.50% per year. And the median was 10.25% per year.

As of today (2026-08-26), Mayinglong Pharmaceutical Group Co's current stock price is ¥23.18. Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ¥0.00. Mayinglong Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Mayinglong Pharmaceutical Group Co was 7.31. The lowest was 2.94. And the median was 4.25.


Mayinglong Pharmaceutical Group Co  (SHSE:600993) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Mayinglong Pharmaceutical Group Co was 7.31. The lowest was 2.94. And the median was 4.25.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Mayinglong Pharmaceutical Group Co Cyclically Adjusted Book per Share Related Terms


Mayinglong Pharmaceutical Group Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mayinglong Pharmaceutical Group Co Cyclically Adjusted Book per Share Chart

Mayinglong Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.10 5.62 6.08 6.58 7.17

Mayinglong Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.85 7.02 7.17 7.34 0.00

SHSE:600993 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mayinglong Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mayinglong Pharmaceutical Group Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayinglong Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mayinglong Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600993
94GF Score
Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mayinglong Pharmaceutical Group Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mayinglong Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.338/116.0564*116.0564
=10.338

Current CPI (Jun. 2026) = 116.0564.

Mayinglong Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 4.417 102.400 5.006
201612 4.501 102.600 5.091
201703 4.702 103.200 5.288
201706 4.763 103.100 5.362
201709 4.900 104.100 5.463
201712 5.086 104.500 5.648
201803 5.242 105.300 5.777
201806 5.097 104.900 5.639
201809 5.141 106.600 5.597
201812 5.257 106.500 5.729
201903 5.588 107.700 6.022
201906 5.636 107.700 6.073
201909 5.788 109.800 6.118
201912 5.923 111.200 6.182
202003 6.186 112.300 6.393
202006 6.203 110.400 6.521
202009 6.417 111.700 6.667
202012 6.610 111.500 6.880
202103 6.865 112.662 7.072
202106 6.881 111.769 7.145
202109 7.115 112.215 7.359
202112 7.357 113.108 7.549
202203 7.676 114.335 7.792
202206 7.636 114.558 7.736
202209 7.969 115.339 8.019
202212 8.107 115.116 8.173
202303 8.454 115.116 8.523
202306 8.323 114.558 8.432
202309 8.627 115.339 8.681
202312 8.672 114.781 8.768
202403 9.078 115.227 9.143
202406 8.944 114.781 9.043
202409 9.281 115.785 9.303
202412 9.433 114.893 9.529
202503 9.905 115.116 9.986
202506 9.608 114.907 9.704
202509 9.974 115.471 10.025
202512 10.161 115.832 10.181
202603 10.654 116.303 10.631
202606 10.338 116.056 10.338

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥0.00 mean?
Mayinglong Pharmaceutical Group Co (SHSE:600993) has a Cyclically Adjusted Book per Share of ¥0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Mayinglong Pharmaceutical Group Co and its competitors.
Is Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Book per Share too high?
Mayinglong Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥0.00. Overall, Mayinglong Pharmaceutical Group Co has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Book per Share compare to ZTS?
Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Book per Share of ¥0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Mayinglong Pharmaceutical Group Co and its competitors. Mayinglong Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayinglong Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co (SHSE:600993) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.81, compared to a current price of ¥23.18 — trading 22.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥0.00. Mayinglong Pharmaceutical Group Co's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Mayinglong Pharmaceutical Group Co (SHSE:600993), the current Cyclically Adjusted Book per Share is ¥0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mayinglong Pharmaceutical Group Co (SHSE:600993) Overvalued in 2026?

Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥23.18 is trading 22.2% below its estimated GF Value™ of ¥29.81. GuruFocus considers Mayinglong Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600993:

  • Cyclically Adjusted Book per Share: ¥0.00
  • GF Value™: ¥29.81 vs. price of ¥23.18 (22.2% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600993 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mayinglong Pharmaceutical Group Co Business Description

Address No. 100 Zhoujiawan, Nanhu, Wuchang District, Wuhan, Hubei, CHN, 430064
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly involved in pharmaceutical development, retailing and wholesaling. The company provides ointments, suppositories, and tablets for hemorrhoids.
94GF Score

Get the complete analysis for SHSE:600993

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.18
Price
¥29.81
GF Value